Nemours has received a grant of $825,000 from the Toy Foundation to develop trauma-informed patient care and play-based interventions. The project aims to reduce traumatic stress in hospitalized children and their families by emphasizing physical and emotional safety through play.
A clinical trial shows that nusinersen, a new medication, is 'transformative' for babies with spinal muscular atrophy, enabling them to show gains in motor function and increasing their chances of survival. The treatment was approved by the FDA for all patients with this progressive neuromuscular disorder.
A study by Nemours Children's Health System found that telemedicine visits for sports medicine appointments saved patients and families an average of $50 in travel costs and 51 minutes in waiting time. Each telemedicine visit also reduced the health system's costs by $24 per patient.
Researchers at Nemours Biomedical Research and University of Delaware have developed a patent-pending process to bridge the gap between 3D cell cultures and high throughput screening techniques. This allows for greater predictability of drug effectiveness and toxicity, leading to lower attrition rates in new medicine development.
A survey by Nemours Children's Health System found that 64% of parents plan to use telemedicine for their child's care within the next year. Parents cite convenience and immediacy as top reasons for using telemedicine, with most rating the experience superior to in-office visits.
The Department of Defense has awarded Nemours a $3.9 million grant to evaluate how physicians use best practice guidelines and strategies to maintain clinical skills. The study will examine patterns in physicians' types of cases and their variability in practice for certain targeted medical conditions.
Research by Nemours and University of Delaware teams found improved quality of life and survival in leukemia patients treated with nanoparticle-based drug delivery. The approach reduces side effects and allows precise targeting of cancer cells, offering a promising alternative to traditional chemotherapy.